The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 53.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 5.00 (9.434%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

30 Jan 2017 07:00

RNS Number : 3696V
MyCelx Technologies Corporation
30 January 2017
 

 

30 January 2017

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

("MYCELX" or the "Company")

Trading Update

MYCELX Technologies Corporation (AIM: MYX), the provider of patented water treatment solutions for the oil and gas and commercial industrial markets worldwide, is pleased to provide a Trading Update.

Throughout 2016, MYCELX continued to demonstrate good operational progress with a recent contract award for a fifth installation of offshore water treatment equipment for a current customer. Additionally, MYCELX commissioned its fourth water treatment system servicing terminals on the Houston Ship Channel and expects the subsequent media sales to begin in 2017.

 

The Board is confident that it will be able to report results for the full year ended 31 December 2016 which are in line with market expectations, and show MYCELX having successfully achieved an operationally cash flow neutral position, in line with its stated target.

 

Since announcing its exclusive marketing and distribution agreement with Schlumberger in June 2016, both companies have collaborated to organize the global marketing initiative that was launched in 4Q 2016 and has been presented in six countries to date. This targeted engagement with industry decision makers is expected to lead to the deployment of MYCELX proprietary water treatment systems, in particular MYCELX's RE-GEN product for the upstream market. Whilst it is too early to forecast the likely 2017 revenue contribution, the pipeline is growing and joint proposal activity is increasing.

 

Overall, the MYCELX contracted order book is stronger than this time last year and the Company therefore envisages a year-on-year revenue increase for 2017 in the range of 30%, with the aim of being EBITDA neutral, and with no material change in cash balance. MYCELX's revenue is already being generated from a broader geographic base than previously. The Company fully expects this positive trend, which is a result of our deliberate efforts to broaden our geographic exposure, to continue.

 

As is widely reported, the investment climate remains uncertain and, consequently, forecasting with any degree of accuracy remains challenging. As such, we will continue to adopt a prudent approach to expenditure, whilst continuing the encouraging international sales and marketing efforts.

 

MYCELX will be providing further guidance at the time of its results for the year ended 31 December 2016, expected to be announced in May 2017.

 

 

Commenting on today's Trading Update, Connie Mixon, CEO, said:

 

"MYCELX's world leading clean water technology solutions continue to gain traction into its core market of the oil & gas sector, and increasingly beyond. Our partnership with Schlumberger is progressing well with the global marketing initiative currently underway. We are also pleased to update on other important operational milestones, such as our further work with a repeat global oil and gas customer. Our progress as a business is firmly underpinned by industry's requirement for innovative technologies to manage their water requirements. We are providing a service that not only significantly enhances the economics of our clients' projects, but that also ensures improved operational efficiencies and performance."

 

"We are pleased to confirm that we will meet guidance for 2016. Looking ahead, this year is expected to continue to show an improved financial performance. However, market uncertainty remains the reality and accurate 2017 full year guidance remains difficult at this stage. That said, we are encouraged by the levels of interest and that the order book is currently ahead of where it was at the same time last year."

 

For further information please contact: 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

Tel: +1 888 306 6843

Cantor Fitzgerald Europe - Nomad and Broker

Andrew Craig

Richard Salmond

 

Tel: +44 20 7894 7000

Celicourt Communications

 Mark Antelme

Joanna Boon

 

Tel: +44 20 7520 9266

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) prior to its release as part of this announcement.

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKODKPBKDNDB
Date   Source Headline
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update
22nd Feb 20247:00 amRNSSaudi Arabia Business Operation Sale
21st Nov 20237:00 amRNSContract Update
16th Nov 20237:00 amRNSTrading Update
26th Sep 20233:10 pmRNSResult of Annual Meeting
20th Sep 20237:00 amRNSHalf Year Results Statement
11th Jul 20237:00 amRNSContract Award
5th Jul 20233:28 pmRNSHolding(s) in Company
3rd Jul 20232:37 pmRNSContract Award & PFAS Update
21st Jun 20237:00 amRNSMailing of AR and Notice of 2023 Annual Meeting
18th May 20237:00 amRNSFinal Results for the Year Ending 31 December 2022
12th May 20237:00 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSSuccessful leach testing of PFAS media
14th Mar 20234:50 pmRNSClosure of Restricted Stock Line
8th Mar 20237:00 amRNSPilot Testing Agreement for PFAS Remediation
13th Feb 20237:00 amRNSOperational Update
31st Jan 20237:00 amRNSTrading Update
24th Jan 20237:00 amRNSContract Secured for PFAS Remediation System
8th Dec 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSHalf Year Results Statement
15th Sep 20227:00 amRNSTrading Update
6th Sep 20222:30 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSNew Project Awards and Operations Update
13th Jul 20223:32 pmRNSResult of Annual Meeting
13th Jun 20227:00 amRNS2021 Annual Report & Notice of 2022 Annual Meeting
17th May 20227:00 amRNSFinal Results for Year Ending 31 December 2021
3rd May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSChange of Main Office Address
23rd Mar 20229:17 amRNSTR1
21st Mar 20225:56 pmRNSBroker Option
16th Mar 20224:09 pmRNSHolding(s) in Company
11th Mar 20221:10 pmRNSDealings by Directors
11th Mar 20227:00 amRNSProposed Placing and Subscription
11th Feb 20227:00 amRNSTrading Update
2nd Feb 202211:07 amRNSHolding(s) in Company
25th Jan 20227:00 amRNSSuccessful Trial of PFAS Remediation System
10th Jan 20227:00 amRNSAward of Green Economy Mark
23rd Nov 20212:36 pmRNSHolding(s) in Company
11th Nov 202111:51 amRNSDealings by Directors
9th Nov 20214:42 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSDirector/PDMR Shareholding
28th Oct 20214:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.